HemaXis DB 10 is Cansford Laboratories Ltd. solution for microsampling in their new PEth testing service. We are so proud to be part of this and contribute to improving patients health! Cansford Laboratories offers the UK’s fastest hair drug and alcohol testing service, while investing in research and development and contributing to conferences and symposia […]
This author has yet to write their bio.Meanwhile lets just say that we are proud hemaxisdbs contributed a whooping 25 entries.
Entries by hemaxisdbs
The group of Prof. Resano of Zaragoza University Department of Analytical Chemistry published a very interesting article about the use of HemaXis™ DB10 for the quantification of mercury in patients’ blood. The study showed excellent reproducibility for samples collected using HemaXis™ DB10. In the conclusion, the authors states that “current DBS microsampling devices show a […]
If you need fully customised kits which could include device, disinfectant, lancet, plasters, envelope, etc. our partner Cibesmed (www.cibesmed.com) will be delighted to tailor a solution for you. You can send your request to email@example.com
Frank Sporkert & Cristian Palmiere will present, during the 15. Gemeinsames Symposium der Deutschen Gesellschaft für Verkehrspsychologie e. V. (DGVP) und der Deutschen Gesellschaft für Verkehrsmedizin e. V. (DGVM) in Bonn, very interesting data on Phosphatidylethanol and driving aptitude in the french-speaking part of Switzerland, measured from HemaXis DB 10.
DBS System becomes member of Lyonbiopôle ! As a Cluster, Lyonbiopole is the gateway to healthcare innovation in the Auvergne-Rhône-Alpes region. It’s supporting ambitious projects and innovative companies in the healthcare & life sciences’ sector. Its aim is to help innovators develop new technologies, products and services in a push toward a more personalized medicine […]
DBS System SA today announced its collaboration with the Union Cycliste Internationale (UCI) and the Center of Research and Expertise in anti-Doping sciences (REDs) to monitor the use of Tramadol in the professional peloton. Following the ban of Tramadol use on March 1, the drug has been tested on 143 samples of 117 professional riders […]
DBS System SA announced today that its blood collection device, HemaXis™ DB 10, has been registered with the Swiss Agency for Therapeutic Products (SwissMedic), and is now CE/IVD marked following the 98/79/EC In vitro Diagnostic Medical Device Directive. HemaXis DB 10 is DBS System’s first-generation device for the collection, transport and storage of a precisely […]
PEth testing is quickly becoming the preferred choice for alcohol consumption monitoring and HemaXis DB offers a complete solution to simplify and improve the PEth testing process. View a summary of the benefits of using HemaXis DB with PEth testing for efficient alcohol consumption monitoring and download an application note developed with ACQ Science to […]
DBS System has launched their HemaXis DB micro blood collection device in the United States with an FDA Class 1 medical device listing. HemaXis DB is DBS System’s first generation device for the collection, transport and storage of capillary whole blood samples. DBS System, a Swiss based company, produces blood collection devices that leverage advanced […]
RTS Interview with our Co-Founder & CTO Dr. Julien Déglon
HemaXis DB is a FDA Class 1 medical device. HemaXis DX is in development and for research purposes only. Use of HemaXis devices in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with local regulatory requirements.
By using this website you are agreeing to our Terms and Conditions.